Literature DB >> 17974689

Management of sepsis.

Iain Mackenzie1, Andrew Lever.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17974689      PMCID： PMC2048841          DOI： 10.1136/bmj.39346.696620.AE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  30 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial.

Authors:  Guido Bertolini; Gaetano Iapichino; Danilo Radrizzani; Rebecca Facchini; Bruno Simini; Paola Bruzzone; Giancarlo Zanforlin; Gianni Tognoni
Journal:  Intensive Care Med       Date:  2003-04-09       Impact factor: 17.440

3.  Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial.

Authors:  Emad H Ibrahim; Lisa Mehringer; Donna Prentice; Glenda Sherman; Robyn Schaiff; Victoria Fraser; Marin H Kollef
Journal:  JPEN J Parenter Enteral Nutr       Date:  2002 May-Jun       Impact factor: 4.016

Review 4.  Intravenous immunoglobulin for treating sepsis and septic shock.

Authors:  M M Alejandria; M A Lansang; L F Dans; J B Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2002

5.  Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.

Authors:  Derek C Angus; Lihong Yang; Lan Kong; John A Kellum; Russell L Delude; Kevin J Tracey; Lisa Weissfeld
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

6.  Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

Authors:  Stephan Harbarth; Jorge Garbino; Jérome Pugin; Jacques A Romand; Daniel Lew; Didier Pittet
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

7.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

8.  Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

Authors:  Peter M Houck; Dale W Bratzler; Wato Nsa; Allen Ma; John G Bartlett
Journal:  Arch Intern Med       Date:  2004-03-22

Review 9.  Clinical review: extracorporeal blood purification in severe sepsis.

Authors:  Ramesh Venkataraman; Sanjay Subramanian; John A Kellum
Journal:  Crit Care       Date:  2003-02-21       Impact factor: 9.097

10.  Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness.

Authors:  Cristina Granja; Cláudia Dias; Altamiro Costa-Pereira; António Sarmento
Journal:  Crit Care       Date:  2004-02-20       Impact factor: 9.097
View more
  10 in total

1.  Surviving sepsis campaign's recommendations.

Authors:  Lindsay E M Reid
Journal:  BMJ       Date:  2007-11-17

Review 2.  Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility.

Authors:  Benedicte-Y De Winter; Joris-G De Man
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

3.  Targeting a bacterial stress response to enhance antibiotic action.

Authors:  Samuel Lee; Aaron Hinz; Elizabeth Bauerle; Angus Angermeyer; Katy Juhaszova; Yukihiro Kaneko; Pradeep K Singh; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

4.  Rapid Hemodynamic Deterioration and Death due to Acute Severe Refractory Septic Shock.

Authors:  Abhijeet Dhoble; Won Chung
Journal:  J Clin Med Res       Date:  2009-06-21

5.  Pyruvate: immunonutritional effects on neutrophil intracellular amino or alpha-keto acid profiles and reactive oxygen species production.

Authors:  D Mathioudakis; J Engel; I D Welters; M G Dehne; R Matejec; H Harbach; M Henrich; T Schwandner; M Fuchs; K Weismüller; G J Scheffer; Jörg Mühling
Journal:  Amino Acids       Date:  2010-09-14       Impact factor: 3.520

6.  Early rehabilitation in sepsis: a prospective randomised controlled trial investigating functional and physiological outcomes The i-PERFORM Trial (Protocol Article).

Authors:  Geetha Kayambu; Robert J Boots; Jennifer D Paratz
Journal:  BMC Anesthesiol       Date:  2011-10-31       Impact factor: 2.217

7.  A model-specific role of microRNA-223 as a mediator of kidney injury during experimental sepsis.

Authors:  James F Colbert; Joshay A Ford; Sarah M Haeger; Yimu Yang; Kyrie L Dailey; Kristen C Allison; Viola Neudecker; Christopher M Evans; Vanessa L Richardson; Kelley S Brodsky; Sarah Faubel; Holger K Eltzschig; Eric P Schmidt; Adit A Ginde
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

8.  Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.

Authors:  Simon Finfer; V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Bengt Gårdlund; John C Marshall; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440

9.  Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empirical therapy for S aureus bacteremia.

Authors:  Anthony D Bai; Lisa Burry; Adrienne Showler; Marilyn Steinberg; Daniel Ricciuto; Tania Fernandes; Anna Chiu; Sumit Raybardhan; George A Tomlinson; Chaim M Bell; Andrew M Morris
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jul-Aug       Impact factor: 2.471

10.  The effect of community-acquired bacteraemia on return to workforce, risk of sick leave, permanent disability pension and death: a Danish population-based cohort study.

Authors:  Michael Dalager-Pedersen; Kristoffer Koch; Reimar Wernich Thomsen; Henrik Carl Schønheyder; Henrik Nielsen
Journal:  BMJ Open       Date:  2014-01-29       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.